Gene · 6833
Papers4,205
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,205
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mannose phosphate isomerase gene mutation leads to a congenital disorder of glycosylation: A rare case report and literature review. | Front Pediatr | 2023 | 37124179 | PubTator, text mining | PubMed |
| Neonatal hyperinsulinism with an ABCC8 mutation: A case report. | World J Clin Cases | 2023 | 37122528 | PubTator, text mining | PubMed |
| Thyrotoxic periodic paralysis in a Caucasian man without identifiable genetic predisposition: a case report. | Thyroid Res | 2023 | 37122018 | PubTator, text mining | PubMed |
| Cold temperature extends longevity and prevents disease-related protein aggregation through PA28γ-induced proteasomes. | Nat Aging | 2023 | 37118550 | PubTator, text mining | PubMed |
| Overexpression of a Short Sulfonylurea Splice Variant Increases Cardiac Glucose Uptake and Uncouples Mitochondria by Regulating ROMK Activity. | Life (Basel) | 2023 | 37109544 | PubTator, text mining | PubMed |
| [Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)]. | Wien Klin Wochenschr | 2023 | 37101022 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with small molecules. | Stem Cell Res Ther | 2023 | 37098639 | PubTator, text mining | PubMed |
| Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier. | J Xenobiot | 2023 | 37092502 | PubTator, text mining | PubMed |
| Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment. | Front Pharmacol | 2023 | 37077811 | PubTator, text mining | PubMed |
| ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control? | J Pediatr Endocrinol Metab | 2023 | 37071846 | PubTator, text mining | PubMed |
| Syndromic forms of congenital hyperinsulinism. | Front Endocrinol (Lausanne) | 2023 | 37065762 | PubTator, text mining | PubMed |
| A plasma membrane-associated glycolytic metabolon is functionally coupled to KATP channels in pancreatic α and β cells from humans and mice. | Cell Rep | 2023 | 37058408 | PubTator, text mining | PubMed |
| KATP channel mutations in congenital hyperinsulinism: Progress and challenges towards mechanism-based therapies. | Front Endocrinol (Lausanne) | 2023 | 37056678 | PubTator, text mining | PubMed |
| Stalled oligodendrocyte differentiation in IDH-mutant gliomas. | Genome Med | 2023 | 37055795 | PubTator, text mining | PubMed |
| Prevalence, clinical features and complications of common forms of Maturity Onset Diabetes of the Young (MODY) seen at a tertiary diabetes centre in south India. | Prim Care Diabetes | 2023 | 37055265 | PubTator, text mining | PubMed |
| Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study. | Eur J Epidemiol | 2023 | 37052755 | PubTator, text mining | PubMed |
| Glycaemic Imbalances in Seizures and Epilepsy of Paediatric Age: A Literature Review. | J Clin Med | 2023 | 37048663 | PubTator, text mining | PubMed |
| Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control. | Int J Mol Sci | 2023 | 37047011 | PubTator, text mining | PubMed |
| Influence of TRPM4 rs8104571 genotype on intracranial pressure and outcomes in African Americans with traumatic brain injury. | Sci Rep | 2023 | 37037835 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. | medRxiv | 2023 | 37034649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6833/papers?page=25